These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10808065)

  • 1. Clinical efficacy of insulin-like growth factor-1 in a patient with autoantibodies to insulin receptors: a case report.
    Yamamoto T; Sato T; Mori T; Yamakita T; Hasegawa T; Miyamoto M; Hosoi M; Ishii T; Yoshioka K; Tanaka S; Fujii S
    Diabetes Res Clin Pract; 2000 Jul; 49(1):65-9. PubMed ID: 10808065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment with plasmapheresis, cyclophosphamide, and cyclosporin A in type B syndrome of insulin resistance. Case report.
    Eriksson JW; Bremell T; Eliasson B; Fowelin J; Fredriksson L; Yu ZW
    Diabetes Care; 1998 Aug; 21(8):1217-20. PubMed ID: 9702422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of type B insulin resistance: a novel approach to reduce insulin receptor autoantibodies.
    Malek R; Chong AY; Lupsa BC; Lungu AO; Cochran EK; Soos MA; Semple RK; Balow JE; Gorden P
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3641-7. PubMed ID: 20484479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of type B insulin resistance with rituximab.
    Manikas ED; Isaac I; Semple RK; Malek R; Führer D; Moeller LC
    J Clin Endocrinol Metab; 2015 May; 100(5):1719-22. PubMed ID: 25675382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type B insulin resistance complicated with systemic lupus erythematosus.
    Kawashiri SY; Kawakami A; Fujikawa K; Iwamoto N; Aramaki T; Tamai M; Nakamura H; Origuchi T; Ida H; Eguchi K
    Intern Med; 2010; 49(5):487-90. PubMed ID: 20190490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case report: Successful combination therapy with double-filtration plasmapheresis and rituximab under the condition of the use of a sensor-augmented pump for type B insulin resistance syndrome.
    Osanami A; Kanda M; Sato T; Akazawa C; Baba S; Komatsu H; Murase K; Yamashita T; Yano T
    Front Endocrinol (Lausanne); 2022; 13():997296. PubMed ID: 36157458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin receptor antibodies and insulin resistance.
    Magsino CH; Spencer J
    South Med J; 1999 Jul; 92(7):717-9. PubMed ID: 10414483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Immunosuppressive Therapy Induces Remission in Patients With Severe Type B Insulin Resistance: A Prospective Cohort Study.
    Klubo-Gwiezdzinska J; Lange M; Cochran E; Semple RK; Gewert C; Brown RJ; Gorden P
    Diabetes Care; 2018 Nov; 41(11):2353-2360. PubMed ID: 30201849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful immunosuppressive therapy in insulin resistant diabetes caused by anti-insulin receptor autoantibodies.
    Kawanishi K; Kawamura K; Nishina Y; Goto A; Okada S
    J Clin Endocrinol Metab; 1977 Jan; 44(1):15-21. PubMed ID: 833253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A patient with type B insulin resistance syndrome, responsive to immune therapy.
    Page KA; Dejardin S; Kahn CR; Kulkarni RN; Herold KC; Inzucchi SE
    Nat Clin Pract Endocrinol Metab; 2007 Dec; 3(12):835-40. PubMed ID: 18026162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful immunosuppressive therapy in a patient with autoantibodies to insulin receptors and immune complex glomerulonephritis.
    Sims RE; Rushford FE; Huston DP; Cunningham GR
    South Med J; 1987 Jul; 80(7):903-6. PubMed ID: 3603112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of systemic lupus erythematosus-associated type B insulin resistance syndrome with cyclophosphamide and mycophenolate mofetil.
    Gehi A; Webb A; Nolte M; Davis J
    Arthritis Rheum; 2003 Apr; 48(4):1067-70. PubMed ID: 12687550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiinsulin receptor autoantibodies induce insulin receptors to constitutively associate with insulin receptor substrate-1 and -2 and cause severe cell resistance to both insulin and insulin-like growth factor I.
    Auclair M; Vigouroux C; Desbois-Mouthon C; Deibener J; Kaminski P; Lascols O; Cherqui G; Capeau J; Caron M
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3197-206. PubMed ID: 10487687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression of acanthosis nigricans correlates with disappearance of anti-insulin receptor autoantibodies and achievement of euglycemia in type B insulin resistance syndrome.
    Fareau GG; Maldonado M; Oral E; Balasubramanyam A
    Metabolism; 2007 May; 56(5):670-5. PubMed ID: 17445543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-insulin receptor autoantibodies in a patient with type B insulin resistance and fasting hypoglycemia.
    Yamasaki H; Yamaguchi Y; Fujita N; Kato C; Kuwahara H; Yamauchi MD; Yamakawa K; Abe T; Ozaki M; Sera Y; Uotani S; Kawasaki E; Takino H; Eguchi K
    Acta Diabetol; 2000; 37(4):189-96. PubMed ID: 11450502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type B Insulin Resistance in Peru.
    Zelada H; Gamarra D; Arbañil H; Manrique H
    Am J Med Sci; 2017 Mar; 353(3):258-262. PubMed ID: 28262212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type B insulin resistance syndrome associated with systemic lupus erythematosus.
    Bao S; Root C; Jagasia S
    Endocr Pract; 2007; 13(1):51-5. PubMed ID: 17360301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab therapy for the type B syndrome of severe insulin resistance.
    Coll AP; Thomas S; Mufti GJ
    N Engl J Med; 2004 Jan; 350(3):310-1. PubMed ID: 14724317
    [No Abstract]   [Full Text] [Related]  

  • 19. Type B Insulin Resistance Masquerading as Ovarian Hyperthecosis.
    Brown RJ; Joseph J; Cochran E; Gewert C; Semple R; Gorden P
    J Clin Endocrinol Metab; 2017 Jun; 102(6):1789-1791. PubMed ID: 27911591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperalimentation as cause of markedly worsened metabolic control in a patient with autoantibodies to the insulin receptor.
    Vesely DL; Coleman MJ; Kohler PO; Jordan RM; Stanley S
    Am J Med; 1985 Oct; 79(4):504-8. PubMed ID: 3931471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.